Institute of Hematology and Blood Transfusion, Czech Republic
5 clinical trials · Sponsor
◉ Watch Institute of Hematology and Blood Transfusion, Czech Republic
| Record | Firm | Date |
|---|---|---|
| Proton-Based Total Marrow Irradiation for Allogeneic Transplantation in High-Risk AML/MDS (NCT07532824) | Institute of Hematology and Blood Transfusion, Czech Republic | 2025-11-21 |
| CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial (NCT06765876) | Institute of Hematology and Blood Transfusion, Czech Republic | 2024-10-23 |
| CART19 Cells Effects in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma (NCT05054257) | Institute of Hematology and Blood Transfusion, Czech Republic | 2021-06-02 |
| Ponatinib Plus Reduced-intensity Chemotherapy in the First-line Treatment of Adult Patients With Ph+ ALL (NCT04554459) | Institute of Hematology and Blood Transfusion, Czech Republic | 2021-02-16 |
| Blinatumomab Followed by High-dose Chemotherapy for Ph-negative Acute Lymphoblastic Leukemia (ALL) (NCT04554485) | Institute of Hematology and Blood Transfusion, Czech Republic | 2019-05-09 |
Track Institute of Hematology and Blood Transfusion, Czech Republic automatically
Every clearance here is in the API, with alerts when new ones post.